EZZ Life Science Holdings Ltd (ASX: EZZ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
EZZ Life Science Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$201.24 million
P/E Ratio
24.98
Dividend Yield
0.62%
Shares Outstanding
44.42 million
Earnings per share
0.081
Dividend per share
0.03
Year To Date Return
357.69%
Earnings Yield
4.00%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
EZZ Life Science Holdings Ltd (ASX: EZZ)
Latest News
Healthcare Shares
Up 630% this year AND profitable! This small ASX healthcare share is glowing
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 16 May 2024 | $0.0150 | 100.00% | Interim | 17 Jun 2024 |
| 30 Oct 2023 | $0.0100 | 100.00% | Final | 08 Dec 2023 |
| 22 May 2023 | $0.0098 | 100.00% | Interim | 23 Jun 2023 |
| 03 Nov 2022 | $0.0045 | 100.00% | Final | 16 Dec 2022 |
| 09 Nov 2021 | $0.0045 | 100.00% | Final | 16 Dec 2021 |
EZZ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About EZZ Life Science Holdings Ltd
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity,human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.
EZZ Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 30 Sep 2024 | $4.53 | $0.49 | 12.13% | 563,579 | $4.24 | $4.74 | $4.24 |
| 27 Sep 2024 | $4.04 | $0.28 | 7.45% | 420,984 | $3.85 | $4.29 | $3.85 |
| 26 Sep 2024 | $3.76 | $0.24 | 6.82% | 122,524 | $3.60 | $3.87 | $3.60 |
| 25 Sep 2024 | $3.52 | $-0.05 | -1.40% | 148,933 | $3.58 | $3.82 | $3.46 |
| 24 Sep 2024 | $3.57 | $0.37 | 11.56% | 353,181 | $3.20 | $3.59 | $3.14 |
| 23 Sep 2024 | $3.20 | $0.30 | 10.34% | 147,398 | $2.93 | $3.20 | $2.87 |
| 20 Sep 2024 | $2.90 | $-0.22 | -7.05% | 285,372 | $3.07 | $3.17 | $2.86 |
| 19 Sep 2024 | $3.12 | $0.04 | 1.30% | 56,140 | $3.20 | $3.20 | $2.95 |
| 18 Sep 2024 | $3.08 | $-0.02 | -0.65% | 155,804 | $3.10 | $3.25 | $3.03 |
| 17 Sep 2024 | $3.10 | $0.04 | 1.31% | 85,014 | $3.01 | $3.10 | $2.95 |
| 16 Sep 2024 | $3.06 | $0.24 | 8.51% | 211,728 | $2.89 | $3.12 | $2.89 |
| 13 Sep 2024 | $2.82 | $-0.32 | -10.19% | 273,568 | $3.19 | $3.19 | $2.71 |
| 12 Sep 2024 | $3.14 | $0.13 | 4.32% | 145,915 | $3.09 | $3.22 | $3.05 |
| 11 Sep 2024 | $3.01 | $-0.39 | -11.47% | 259,196 | $3.40 | $3.40 | $2.89 |
| 10 Sep 2024 | $3.40 | $0.44 | 14.86% | 273,378 | $2.97 | $3.40 | $2.97 |
| 09 Sep 2024 | $2.96 | $0.11 | 3.86% | 175,221 | $2.84 | $2.98 | $2.77 |
| 06 Sep 2024 | $2.85 | $-0.03 | -1.04% | 82,072 | $2.87 | $2.87 | $2.75 |
| 05 Sep 2024 | $2.88 | $0.10 | 3.60% | 105,201 | $2.85 | $2.97 | $2.80 |
| 04 Sep 2024 | $2.78 | $0.08 | 2.96% | 162,855 | $2.66 | $2.78 | $2.57 |
| 03 Sep 2024 | $2.70 | $-0.20 | -6.90% | 122,598 | $2.90 | $2.90 | $2.56 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 21 Aug 2024 | Ivan Oshry | Issued | 15,000 | $1,200 |
Issued under employee share plan.
|
| 21 Aug 2024 | Lily (Hao) Huang | Issued | 15,000 | $1,200 |
Issued under employee share plan.
|
| 21 Aug 2024 | Glenn Cross | Issued | 15,000 | $1,200 |
Issued under employee share plan.
|
| 11 Oct 2023 | Glenn Cross | Buy | 26,000 | $16,900 |
On-market trade.
|
| 11 Oct 2023 | Glenn Cross | Buy | 40,000 | $26,000 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Ivan Oshry | Non-Executive Director | Oct 2020 |
Mr Oshry has more than 30 years of experience of legal practice in Australia and internationally, specializing in commercial and corporate law. Mr Oshry was formerly a senior partner at Fluxmans Attorneys in Johannesburg and headed up the corporate department at Kemp Strang (which was merged with Thomson Geer) in Sydney. He is also Chair of Risk Committee and Human Resources Committee.
|
| Ms Lily (Hao) Huang | Non-Executive Director | Oct 2020 |
Ms Huang has over 20 years of experience in the wealth management and banking industry. She has been working with Citi Group Australia since 2017 as Vice President of the APAC Desk of the Investment Partnerships Division. She is Chair of Human Resources and Risk Committee.
|
| Mr Mark (Qizhou) Qin | Chief Operating OfficerExecutive DirectorInterim Chief Executive Officer | Sep 2018 |
Mr Qin has a background in management consulting and experience in sales and marketing. Mr Qin also authored five books in sales and marketing for the consumer health industry between 2003 and 2008.
|
| Mr Glenn Walter Cross | Non-Executive ChairmanNon-Executive Director | Dec 2021 |
Mr Cross has 40 years of experience in life science sector domestically and internationally, including over 20 years in a senior executive capacity. He was formerly CEO and COO of AusBiotech over a period spanning 13 years. He is member of the Risk Committee and Human Resources Committee.
|
| Ms Natalie Sylvia Climo | Company Secretary |
-
|
|
| Anthony Guarna | Chief Financial Officer |
-
|
|
| Natalie Sylvia Climo | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Macquarie Holdings Pty Ltd | 17,016,000 | 39.85% |
| JNJ Mok Pty Ltd | 11,344,000 | 26.56% |
| Dr Mohammed Nabil Mohammed Eltokhy | 557,091 | 1.32% |
| Dr Mohammed Nabil Mohammed Eltokhy & Mrs Rana Farouk Mohamed <Mnt Super A/C> | 500,000 | 1.17% |
| Rana Farouk Mohamed <Mnt Super A/C> | 486,000 | 1.14% |
| Mars Family Investment Pty Ltd <Mars Family A/C> | 480,000 | 1.12% |
| Miss Jing Chen | 480,000 | 1.12% |
| Mr Haitao Zheng | 480,000 | 1.12% |
| BNP Paribas Nominees Pty Ltd < IB AU Noms Retail Client Drp> | 421,358 | 0.99% |
| Ms Xiaojing Wang | 150,000 | 0.35% |
| Mr Ying Chuang Wang | 147,005 | 0.34% |
| Stephen Anthony Mander | 120,040 | 0.28% |
| Merrill Lynch (Australia) Nominees Pty Limited | 116,060 | 0.27% |
| Bai Nominees Pty Ltd <Bai Superannuation Fund A/C> | 108,972 | 0.26% |
| D & T Superannuation Pty Ltd <Suntan Super Fund A/C> | 100,000 | 0.23% |
| Ms Dandan Li | 100,000 | 0.23% |
| Peter Cowen Pty Ltd <Peter Cowen Super Fund A/C> | 100,000 | 0.23% |
| Mrs Li Zhu <Knight Holding Fund A/C> | 95,229 | 0.22% |
| Mr Xianfeng Gao & Ms Yang Sun | 87,887 | 0.21% |
| Wang Brothers Pty Ltd <Wang Brothers Family A/C> | 81,135 | 0.19% |
